Select Language
Chinese (Simplified)
Chinese (Traditional)
English
French
German
Japanese
Korean
Spanish
HOME
新聞
服務
訂閱
廠商
EN
關於
下載 APP
聯絡
查看購物車
請選擇單元
每日新聞
市場分析
生醫人物
創新創業
展會直擊
雜誌報導
出版品
搜尋
會員登入
註冊
生醫新聞
每日新聞
生技醫藥
醫療科技
再生醫學/細胞治療
科學新知
政策法規
應用生技
論壇報導
新聞集錦
GBI International
商情中心
產業分析
公司重訊
漲跌排名
生醫永續
查找廠商
焦點人物
生醫人物
人物專訪
國際報導
專家觀點
生醫名人錄【影】
編輯專欄
創業投資
新創動態
投募專區
生醫攬才
【影】技術焦點鏡
產業活動
活動報名
活動快訊
亞洲生技大會快訊
生技雜誌
出版品
線上閱讀
編輯部公告
新聞
GBI International
NEW
Decode Your Genome & Metabolome: Craft Your Personalized Health Blueprint!
新聞集錦
NEW
高端攜法國Substipharm簽腸病毒疫苗經銷合約;禮來減重藥睡眠中止症用途獲Medicare納保;三星生物製藥擴LigaChem開發ADC合作
生技醫藥
NEW
MaaT微生物體療法急性GVHD臨床三期積極 將申請歐洲藥證
GBI International
GBIHighlights
Healthcare
MedicalTech
Globalbio magazine volume 112
2024-01-25/
GlobalBio & Investment
Involume112,Globalbiomagazinedivesintothenutsandboltsofimplementinginnovativemedicaltech. Breakingthroughthebarriersfromresearchtoclinicaltrialsisjustthestart,buttherealchallengekicksinaftervalidation...
GBI International
GBIHighlights
DigitalPathology
TFDA
TFDA certified Jellox Biotech's 'MetaLite DX Digital Pathology Software' as SaMD
2024-01-25/
GlobalBio & Investment
BigkudostoJelloxBiotechforreachingasignificantregulatorymilestone!TFDAcertifiedtheir'MetaLiteDXDigitalPathologySoftware'as#SaMD(SoftwareasMedicalDevice)thismonth,markingitthefirstofflineusable...
GBI International
GBIHighlights
ADCs
Healthcare
The latest progress of ADC drug development in Taiwan
2024-01-25/
GlobalBio & Investment
Antibody-drugconjugates(ADCs)featurespecificityandpotentchemotherapy.Sincetheirbreakthroughintreatingsolidtumorsin2019,ADCshavebecomeahotspotforstrategicalliancesandacquisitionsamongpharmaceuticalcomp...
GBI International
GBIHighlights
CAR-T
Healthcare
Biotech
celltherapy
The latest progress of six Taiwanese CAR-T therapy developers
2024-01-25/
GlobalBio & Investment
GlobalCAR-Tdevelopmentisbustling!AlthoughTaiwanenteredtheCAR-Tfieldlateandfacedhurdleslikepatents,severalcompaniesaretargetingCAR-Tandtakingchallengestomeettheunmetneeds.Theirclinicaltrialsareexpected...
GBI International
GBIHighlights
Diabetes
TFDA
IVD
HealthTech
Bio Preventive Medicine Corp.'s DNlite-IVD103 granted TFDA approval
2024-01-25/
GlobalBio & Investment
"Bettersafethansorry."CongratulationstoBioPreventiveMedicineCorp.fortheirinnovativekidneydiseasetestkit,DNlite-IVD103,grantedTFDAapproval!Thisbreakthroughbenefitsdiabeticpatientsbypredicting...
GBI International
GBIHighlights
Biotech
COVID19
Vaccine
BIOInsights
MVC
蘇益仁
Prof. Ih-Jen Su on Taiwan's biotech industry through the lens of the MVC COVID-19 Vaccine incident
2024-01-25/
GlobalBio & Investment
WhatKOLssay:Prof.Ih-JenSuonTaiwan'sbiotechindustrythroughthelensoftheMVCCOVID-19Vaccineincident. ThedevelopmentofCOVID-19vaccineshaspresentedarobustcompetitionmodelforthebiotechindustry.Onlycompan...
GBI International
GBIHighlights
VYSIONEER Collaborates with MC Medical to Introduce the First-ever Brain Tumor Auto Contouring AI
2024-01-25/
GlobalBio & Investment
Vysioneer,aleadinginnovatorinOncologyAI,isproudtoannounceastrategiccollaborationwithMCMedical,asubsidiaryofMitsubishiCorporationandawhollyownedsubsidiaryofMCHealthcareHoldingsforbringingadvancedmedica...
GBI International
GBIHighlights
Rockwell Automation is now venturing into Taiwan's biotech industry
2024-01-25/
GlobalBio & Investment
EmbracingthefutureofSmartManufacturing(SM),globalindustrialautomationleaderRockwellAutomationisexpandingitsfocustoincludeTaiwan'sbiotechindustry.RecognizingthepivotalroleofTaiwan'sbiopharmaceu...
GBI International
GBIHighlights
From bench to bedside, Prof. Tian-Lu Cheng guides us through the journey of innovation
2024-01-25/
GlobalBio & Investment
Frombenchtobedside,Prof.Tian-LuChengguidesusthroughthejourneyofinnovation,startingwithpatentexploration. Navigatingfromthelaboratorytoindustryapplicationsandeventuallytostartups,thepathfrom20innovativ...
GBI International
GBIHighlights
Gene Lay, founder of BioLegend, turned $262,500 into nearly 300 times its value in just a decade
2024-01-25/
GlobalBio & Investment
DiscovertheincrediblejourneyofGeneLay,thefounderofBioLegend,whoturnedaninitialinvestmentof$262,500intonearly300timesitsvalueinjustadecade! GeneLaysharedhisentrepreneurialsuccessstoryatthe"2024Bio...
GBI International
GBIHighlights
Bora Expands Globally with $210 Million Acquisition of Upsher-Smith
2024-01-25/
GlobalBio & Investment
BreakingNewsinTaiwan!BiotechgiantBoraPharmaceutical(6472-TW)makeswaveswithanotherstrategicmove!Onthe16th,BoraannounceditsfirstU.S.acquisition—Upsher-Smith,acentury-oldpharmaceuticalcompany,atast...
GBI International
GBIHighlights
Meet the startup CEO. Miko Wen
2024-01-25/
GlobalBio & Investment
MikoWen,CEOandfounderofTaiwanEarning,atrailblazerincomparativemedicine,isbridgingthegapbetweenhumanandpethealthcare.With96%sharedgenes,dogsplayacrucialroleinunderstandingdiseases.Recentstudieshintatth...
第一頁
上一頁
184
185
186
187
188
下一頁
最後頁
當期雜誌
查看更多
RNA核酸藥品掀狂熱 引領10年藥物大未來?!
記者列表
查看更多
記者 彭梓涵
記者 王柏豪
記者 吳培安
記者 李林璦
記者 鄔麗.巴旺
影音專區
查看更多
【影音】2024第三屆環球生技臺灣新創CEO獎